Dr. Allewelt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2501 N Orange Ave
Ste 589, Room Hd513
Orlando, FL 32804
Education & Training
- Duke University HospitalFellowship, Pediatric Hematology/Oncology, 2012 - 2015
- University of FloridaResidency, Pediatrics, 2009 - 2012
- University of Miami Leonard M. Miller School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2020 - 2026
- FL State Medical License 2016 - 2022
- NC State Medical License 2012 - 2017
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia.Benjamin M Heyman, Stephen S Opat, Björn E Wahlin, Meletios-Athanasios C Dimopoulos, Jorge J Castillo
Blood Advances. 2025-02-25 - 4 citationsBiomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.Constantine S Tam, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee
Blood Advances. 2024-04-09 - Health-related quality of life in patients with Waldenström macroglobulinemia: results from the ASPEN trial.Alessandra Tedeschi, Constantine S Tam, Roger G Owen, Christian Buske, Véronique Leblond
Future Oncology. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: